Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 5078 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d568-b369-71d0-9f81-48f7dca8788f

adms:identifier	mi-legislature-measure 2023-2024/HB/5078
dcterms:temporal	Michigan Legislature, 2023-2024 session
enacted as	2024 PA 232
primary sponsor	Carrie Rheingans
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5078 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5078 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5078
schema:legislationChanges	MCL 333.17744b
schema:legislationIdentifier	HB 5078
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; distribution of opioid antagonists by employees and agents of agencies under the administration of opioid antagonists act; provide for. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b ).en
schema:sponsor	Regina Weiss Erin Byrnes Noah Arbit Joey Andrews Carrie Rheingans Jennifer Conlin Ann M. Bollin Sharon MacDonell Jasper Martus Julie Brixie Kara Hope Emily Dievendorf John Fitzgerald Curtis S VanderWall Betsy Coffia David Prestin Abraham Aiyash Lori Stone Felicia Brabec Christine Morse Jim Haadsma Rachel Hood Jenn Hill
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-5078
skos:prefLabel	HB 5078 (2023-2024)en